rs377209424
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM5PP2PP3_StrongPP5_Very_Strong
The NM_000372.5(TYR):c.635G>A(p.Arg212Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,613,406 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R212I) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000372.5 missense
Scores
Clinical Significance
Conservation
Publications
- oculocutaneous albinism type 1Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- oculocutaneous albinism type 1AInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
- Waardenburg syndrome type 2Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- minimal pigment oculocutaneous albinism type 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- oculocutaneous albinism type 1BInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- temperature-sensitive oculocutaneous albinism type 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152134Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251218 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461272Hom.: 0 Cov.: 33 AF XY: 0.00000550 AC XY: 4AN XY: 726914 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152134Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74300 show subpopulations
ClinVar
Submissions by phenotype
not provided Pathogenic:2
This sequence change replaces arginine, which is basic and polar, with lysine, which is basic and polar, at codon 212 of the TYR protein (p.Arg212Lys). This variant is present in population databases (rs377209424, gnomAD 0.004%). This missense change has been observed in individual(s) with ocular albinism (PMID: 13680365, 28976636). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 437182). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TYR protein function with a positive predictive value of 80%. This variant disrupts the p.Arg212 amino acid residue in TYR. Other variant(s) that disrupt this residue have been observed in individuals with TYR-related conditions (PMID: 19865097, 31077556, 31199599), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. -
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31589614, 28976636, 13680365, 34838614) -
Oculocutaneous albinism type 1A Pathogenic:1
- -
Oculocutaneous albinism type 1B;C2677190:SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;C4551504:Oculocutaneous albinism type 1A Pathogenic:1
- -
TYR-related disorder Pathogenic:1
The TYR c.635G>A variant is predicted to result in the amino acid substitution p.Arg212Lys. This variant has been reported in the compound heterozygous state in individuals with oculocutaneous albinism (King et al. 2003. PubMed ID: 13680365; Marti et al. 2017. PubMed ID: 28976636; Table S1, Wei et al. 2021. PubMed ID: 34838614). Alternate substitutions of this amino acid (p.Arg212Thr and p.Arg212Ser) have also been reported in individuals with oculocutaneous albinism (Wei et al. 2010. PubMed ID: 19865097; Lin et al 2019. PubMed ID: 31199599). This variant is reported in 0.0039% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Given the evidence, we interpret this variant as pathogenic. -
SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at